REFERENCES
- Global Alliance of Mental Illness Advocacy Networks (2003) AHEAD survey. Lundbeck, Copenhagen, Denmark.
- Paykel ES, Ramana R, Cooper Z et al (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25: 1171–80.
- Lam RW, Lin D, Dawson M et al (2002) Remission rates in antidepressant studies: a systematic review. J Affect Disord 68: 121–2.
- Thase M, Entsuah R, Rudolph R (2001) Remission rates during treatment with venlafaxine or selective-serotonin reuptake inhibitors. Br J Psychiatry 178: 234–41.
- Plenge P, Mellerup ET, Laursen H (1991) Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets. Eur J Pharmacol 206: 243–50.
- Owens MJ, Knight DL, Nemeroff CB (2001) Second-generation SSRIs: human monoamine transporter binding profile of escitalo- pram and R-fluoxetine. Biol Psychiatry 50: 345 -50.
- Sa´nchez C, Bøgesø K, Ebert B et al (2004) Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychophar- macol 174: 163–76.
- Chen F, Larsen MB, Sa´nchez C, Wiborg O (2003) The S-enan- tiomer of citalopram increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Poster presented at the 16th European College of Neuropsychopharmacology (ECNP), 20 -24 September 2003, Prague, Czech Republic.
- Gorman J, Korotzer A, Su G (2002) Efficacy comparison of escitalopram and citalopram in treatment of major depressive disorder. CNS Spectrums 7 (Suppl 1): 40–4.
- Lepola UM, Loft H, Reines EH (2003) Escitalopram (10 -20 mg/ day) is effective and well-tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 18: 211–7.
- Montgomery SA, Huusom AKT, Bothmer J (2004) A randomised study comparing escitalopram with venlafaxine XR in patients in primary care with major depressive disorder. Neuropsychobiology 50: 57–64.
- Bielski RJ, Ventura D, Chang C, Korotzer A (2003) Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorder. Eur Neuropsychopharmacol 13 (Suppl 4): S263.